Replies to post #305 on Bausch Health Companies Inc (BHC)

[seasonedwell]

What's the PE.....?


For 2016, Valeant expects adjusted earnings to range between $13.25 and $13.75 per share.

[seasonedwell]

VRX is cutting cost to the end user (WAG deal) ahead of the curve reducing profit 2016. This will eliminate the problems associated with the hearings and the public backlash (hopefully).

Is that so hard to understand?

Then there will be double digit organic growth in 2017.... I'll hold my 75 dollar shares into 2017....And maybe beyond

[seasonedwell]

Your statement is inaccurate.

Revises numbers downward - and yet, STILL the stock climbs by 8 % !

We had no numbers until the investor conference. The prior guidance was taken off the table by the company a month or so ago. So now there is guidance to make a valuation call....